Princess Anna Mazowiecka Hospital, Warsaw, Poland
14
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Ultrasound Assessment for Predicting Optimal Umbilical Venous Catheter Placement
Role: lead
Hematological Profiles of Preterm Infants and the Impact of Antenatal Steroids
Role: lead
Evaluation of Haemodynamic in Neonates Treated With Hypothermia"
Role: lead
Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
Role: lead
The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.
Role: lead
Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates
Role: lead
Dedicated Lactation Support in Infants With Tongue - Tie; a Randomised Control Trial
Role: lead
Enteral Feeding in Infants With Duct Dependant Lesions.
Role: lead
The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants
Role: lead
Targeted vs Standard Fortification of Breast Milk
Role: lead
Ultrasound and Functional Thyroid Evaluation
Role: lead
Monitored vs Standard Supplementation of Vitamin D in Preterm Infants
Role: lead
Imaging Modalities in Diagnosing Necrotizing Enterocolitis in Preterm Infants.
Role: lead
The Risk of Hyperbilirubinemia in Term Newborns After Placental Transfusion
Role: lead
All 14 trials loaded